Wegovy

Healthcare

Novo Nordisk’s Doing Brilliantly, Just Not Brilliantly Enough

Photo via Novo Nordisk

Novo Nordisk reported earnings, posting some chunky year-over-year growth and far outperforming its only real rival at the moment, Eli Lilly.

1 min read

Photo by Jetcityimage via iStock

Healthcare

Eli Lilly’s Weight-Loss Drug Finally Off FDA Shortage List

The Food and Drug Administration declared an end to the scarcity of Eli Lilly’s highly in-demand weight-loss and diabetes drugs on Thursday.

1 min read
Photo by Chemist4U via CC BY-SA 2.0

Healthcare

Making Weight-Loss Drugs Takes a Whole Lot of Muscle

In the obesity drug industry, two players have really been throwing their weight around. There isn’t a third in sight.

1 min read
Photo by News Øresund – Johan Wessman via CC BY 2.0

Markets

Novo Nordisk Slips Amid Disappointing Wegovy Sales

Novo Nordisk’s share price fell over 8% on Wednesday after the company reported lower-than-expected sales of Wegovy.

2 min read

Photo via Ray-Ban

Big Tech

Meta Looks Back to the Metaverse with Rose-Tinted Ray-Bans

By expanding its partnership with Ray-Ban, Meta is turning its attention back to building futuristic hardware.

2 min read
Photo by Tima Miroshnichenko via Pexels

CIO Upside

How CIOs Can Prepare for the Not-So-Distant Quantum Security Threat

‘What’s more concerning is that people are just waiting and doing nothing’

2 min read
Photo of IBM patent via the U.S. Patent and Trademark Office

Artificial Intelligence

The Less You Know, the Better: Tech Moves Toward Data Minimization

‘At the end of the day, wherever that data is, it has to be protected’

2 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.